过去一年中添加的文章，按日期排序
Abstract PO3-05-12: Randomized Phase 2 of Bria-IMT, an Allogenic Human Cell Line with Antigen Presenting Activity, in Heavily Pretreated Metastatic Breast Cancer
C Calfa, C Nangia, M Barve, J Knecht, J Holmes… - Cancer Research, 2024 - AACR
70 天前 - … with a trend showing longer median durations on therapy (… with prior CPI use
exceeded last therapy. AEs were mild with … with encouraging changes in peripheral blood tumor …
exceeded last therapy. AEs were mild with … with encouraging changes in peripheral blood tumor …
Research History, Current Trends, and Future Prospects of Liquid Biopsy in Triple-Negative Breast Cancer: An Analysis from a Global Perspective
Y Qu, J Wan, R Li, X Li, H Li, Y Li, S Huang, T Zhang… - 2024 - researchsquare.com
96 天前 - … , suggesting great potential and promise in this area. The … as biomarkers and
therapeutic targets in TNBC research. … Early screening for breast cancer is crucial for therapeutic …
therapeutic targets in TNBC research. … Early screening for breast cancer is crucial for therapeutic …
Prevalence and spectrum of PIK3CA mutations in Indian breast cancer patients
R Katara, T Bhardwaj, M Rawat, DK Sharma, V Kumar… - Cancer Research, 2024 - AACR
111 天前 - … trend has recently slowed emphasizing on new breast … by HER2-directed therapies
such as Trastuzumab Deruxtecan. … and have shown promising clinical outcome leading to …
such as Trastuzumab Deruxtecan. … and have shown promising clinical outcome leading to …
Glucocorticoid Receptor Interacts with B-cell Lymphoma 2 for Domineering Aggressiveness of Breast Cancer: An Observational Study
D Thakur, S Kar, D Sengupta… - Journal of Current …, 2024 - journals.lww.com
192 天前 - … stratifying breast cancer (BC) patients during endocrine-targeted therapy, except
triple-negative … further extensive research to establish GR and Bcl-2 as promising targets in BC. …
triple-negative … further extensive research to establish GR and Bcl-2 as promising targets in BC. …
167 Increased programmed cell death 1 ligand 2 (PD-L2) protein and transcript levels in triple negative breast cancer patients improve prognostic value through …
253 天前 - … Recent advances in immunotherapy have shown promising results in triple-negative
breast cancer (… These findings further corroborate PDL2 as a potential therapeutic target for …
breast cancer (… These findings further corroborate PDL2 as a potential therapeutic target for …